PerioHealth Clinic Houston Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2015
NCT02313883
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

PerioHealth Clinic Houston

Active Ingredients

Drugs in Phase 2 Trials (1)

taurolidine (Defencath) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Periodontitis (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 1